Rayos and Osteoarthritis aggravated - a phase IV clinical study of FDA data

Summary:

Osteoarthritis aggravated is reported only by a few people who take Rayos.

The phase IV clinical study analyzes which people take Rayos and have Osteoarthritis aggravated. It is created by eHealthMe based on reports of 559 people who have side effects while taking Rayos from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 17, 2023

559 people reported to have side effects when taking Rayos.
Among them, 4 people (0.72%) have Osteoarthritis aggravated.


What is Rayos?

Rayos has active ingredients of prednisone. It is often used in systemic lupus erythematosus. eHealthMe is studying from 727 Rayos users for its effectiveness, alternative drugs and more.

What is Osteoarthritis aggravated?

Osteoarthritis aggravated (worse joint disease caused by cartilage loss in a joint) is found to be associated with 805 drugs and 316 conditions by eHealthMe.

Number of Rayos and Osteoarthritis aggravated reports submitted per year:

Could Rayos cause Osteoarthritis aggravated?

Gender of people who have Osteoarthritis aggravated when taking Rayos *:

  • female: 100 %
  • male: 0.0 %

Common drugs people take besides Rayos *:

  1. Humira: 3 people, 75.00%
  2. Cimzia: 3 people, 75.00%
  3. Vitamin D: 1 person, 25.00%
  4. Prilosec: 1 person, 25.00%
  5. Plaquenil: 1 person, 25.00%
  6. Orencia: 1 person, 25.00%
  7. Neurontin: 1 person, 25.00%
  8. Advil: 1 person, 25.00%

Common side effects people have besides Osteoarthritis aggravated *:

  1. Joint Effusion (presence of extra fluid in joint covering): 3 people, 75.00%
  2. Red Blood Cell Sedimentation Rate Increased: 3 people, 75.00%
  3. Drug Ineffective: 3 people, 75.00%
  4. Vitamin D Decreased: 3 people, 75.00%
  5. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 3 people, 75.00%
  6. Pain: 3 people, 75.00%
  7. Fatigue (feeling of tiredness): 3 people, 75.00%
  8. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 75.00%
  9. Arthritis Reactive (autoimmune condition that develops in response to an infection in another part of the body): 3 people, 75.00%
  10. Sacroiliitis (an inflammation of the sacroiliac joint): 3 people, 75.00%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rayos and have Osteoarthritis aggravated?

Check whether Osteoarthritis aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Osteoarthritis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of prednisone:

Alternative drugs to, pros and cons of Rayos:

Osteoarthritis aggravated treatments and more:

COVID vaccines that are related to Osteoarthritis aggravated:

Common drugs associated with Osteoarthritis aggravated:

All the drugs that are associated with Osteoarthritis aggravated:

Common conditions associated with Osteoarthritis aggravated:

All the conditions that are associated with Osteoarthritis aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Rayos) and Rayos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: